| Literature DB >> 29357792 |
Gayong Shim1, Dongyoon Kim1, Quoc-Viet Le1, Gyu Thae Park1, Taekhyun Kwon1, Yu-Kyoung Oh1.
Abstract
Gene therapy has been receiving widespread attention due to its unique advantage in regulating the expression of specific target genes. In the field of cancer gene therapy, modulation of gene expression has been shown to decrease oncogenic factors in cancer cells or increase immune responses against cancer. Due to the macromolecular size and highly negative physicochemical features of plasmid DNA, efficient delivery systems are an essential ingredient for successful gene therapy. To date, a variety of nanostructures and materials have been studied as nonviral gene delivery systems. In this review, we will cover nonviral delivery strategies for cancer gene therapy, with a focus on target cancer genes and delivery materials. Moreover, we will address current challenges and perspectives for nonviral delivery-based cancer gene therapeutics. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Cancer gene therapy; DNA; Macromolecular; Nonviral delivery; Nonviral gene therapy; Target cancer gene.
Mesh:
Year: 2018 PMID: 29357792 DOI: 10.2174/1566523218666180119121949
Source DB: PubMed Journal: Curr Gene Ther ISSN: 1566-5232 Impact factor: 4.391